Absolute vs. relative numbers in evaluating drug therapy.
McCormack
J
J
D019386:Alendronate / Q000191:economics / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D007258:Informed Consent; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000517:prevention & control*; D010353:Patient Education as Topic / Q000379:methods*; D018579:Patient Selection; D000068296:Risedronic Acid; D018570:Risk Assessment; D012307:Risk Factors
D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate